ATRC AtriCure Inc

Price (delayed)

$40.52

Market cap

$1.88B

P/E Ratio

34.05

Dividend/share

N/A

EPS

$1.19

Enterprise value

$1.9B

AtriCure, Inc. provides innovative technologies for the treatment of Afib and related conditions. Afib affects more than 33 million people worldwide. Electrophysiologists and cardiothoracic surgeons around the globe use AtriCure ...

Highlights
ATRC's net income has soared by 194% YoY and by 2.7% QoQ
AtriCure's EPS has soared by 193% YoY and by 3.5% from the previous quarter
AtriCure's quick ratio has decreased by 12% QoQ

Key stats

What are the main financial stats of ATRC
Market
Shares outstanding
46.42M
Market cap
$1.88B
Enterprise value
$1.9B
Valuations
Price to earnings (P/E)
34.05
Price to book (P/B)
4.11
Price to sales (P/S)
6.11
EV/EBIT
32.69
EV/EBITDA
27.31
EV/Sales
6.28
Earnings
Revenue
$302.78M
EBIT
$58.17M
EBITDA
$69.63M
Free cash flow
-$32.11M
Per share
EPS
$1.19
Free cash flow per share
-$0.7
Book value per share
$9.87
Revenue per share
$6.63
TBVPS
$6.82
Balance sheet
Total assets
$587.39M
Total liabilities
$130.68M
Debt
$74.97M
Equity
$456.71M
Working capital
$149.85M
Liquidity
Debt to equity
0.16
Current ratio
3.66
Quick ratio
2.84
Net debt/EBITDA
0.29
Margins
EBITDA margin
23%
Gross margin
74.8%
Net margin
17.6%
Operating margin
-43.4%
Efficiency
Return on assets
8.9%
Return on equity
11.3%
Return on invested capital
19.2%
Return on capital employed
11%
Return on sales
19.2%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ATRC stock price

How has the AtriCure stock price performed over time
Intraday
1.27%
1 week
5.93%
1 month
-5.37%
1 year
-39.71%
YTD
-41.72%
QTD
3.63%

Financial performance

How have AtriCure's revenue and profit performed over time
Revenue
$302.78M
Gross profit
$226.36M
Operating income
-$131.54M
Net income
$53.34M
Gross margin
74.8%
Net margin
17.6%
ATRC's net income has soared by 194% YoY and by 2.7% QoQ
The net margin has soared by 176% YoY
The operating income has plunged by 175% YoY
The operating margin has dropped by 121% year-on-year but it has grown by 5% since the previous quarter

Growth

What is AtriCure's growth rate over time

Valuation

What is AtriCure stock price valuation
P/E
34.05
P/B
4.11
P/S
6.11
EV/EBIT
32.69
EV/EBITDA
27.31
EV/Sales
6.28
AtriCure's EPS has soared by 193% YoY and by 3.5% from the previous quarter
The price to earnings (P/E) is 40% lower than the last 4 quarters average of 56.3
ATRC's price to book (P/B) is 32% lower than its last 4 quarters average of 6.0 and 27% lower than its 5-year quarterly average of 5.6
The equity has grown by 19% YoY
ATRC's P/S is 39% below its last 4 quarters average of 10.0 and 20% below its 5-year quarterly average of 7.6
ATRC's revenue is up by 25% year-on-year and by 4.5% since the previous quarter

Efficiency

How efficient is AtriCure business performance
AtriCure's ROS has soared by 190% YoY but it has decreased by 2% from the previous quarter
The ROE has soared by 180% YoY
AtriCure's return on assets has increased by 7% QoQ
The company's return on invested capital rose by 2.1% QoQ

Dividends

What is ATRC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ATRC.

Financial health

How did AtriCure financials performed over time
The total liabilities has dropped by 59% year-on-year but it has grown by 7% since the previous quarter
AtriCure's total assets has decreased by 16% YoY
The debt is 84% less than the equity
The equity has grown by 19% YoY
The debt to equity has declined by 16% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.